Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,243,055
-$4,138,323 QoQ
Shares Held
381,851
+1.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#213
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. GILD ranks #5 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,243,055 | 381,851 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $52,381,378 | 375,844 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,715,461 | 299,132 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,394,567 | 345,897 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,287,070 | 282,196 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,123,877 | 250,994 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,650,507 | 256,041 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,393,285 | 255,168 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,310,421 | 281,452 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,862,096 | 148,288 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,730,136 | 95,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,462,896 | 179,649 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,555,001 | 111,003 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,274,266 | 99,726 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,809,793 | 79,322 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,872,091 | 78,977 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,739,923 | 92,864 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,153,966 | 103,515 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,197,626 | 85,355 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,173,637 | 117,017 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,392,273 | 92,830 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,613,846 | 102,334 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,604,594 | 147,693 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,188,170 | 66,279 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,023,006 | 91,279 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,710,929 | 156,647 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||